Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cann Group (CAN) may have lost around $3.6 million in a recent cyber security breach
  • On Febuary 4, payments made by Cann to an overseas contractor were received by an unknown third party
  • Cann has been working with its bank to determine if any payments can be halted or recovered
  • The incident is being investigated thoroughly by Cann and its overseas contractor, with the help of external security and forensic IT experts
  • The company says operations and projects will continue, irrespective of the money being recovered
  • Cann is in the grey, with shares trading at 66 cents

Cann Group (CAN) may have lost around $3.6 million in a recent cyber security breach.

On February 4, Cann Group made payments of around $3.6 million to an overseas contractor for works being undertaken at its Milura factory.

Overnight, however, the funds were intercepted by an unknown third party in a complex cyber fraud effort.

Acting quickly, Cann began working with its bank to determine if any of the payments could be halted or recovered. Insurance brokers were also immediately notified to determine if a claim can be made to recover any of the losses involved.

Meanwhile, Cann is also working to weed out any issues towards the integrity of its IT systems.

The company says despite the loss it is able to continue to grow its operations and projects, including the construction of its Mildura facility, regardless of any funds being recovered.

The incident is now being investigated thoroughly by both Cann and its overseas contractor, with the help of external security and forensic IT experts.

The matter has been reported to police in Victoria, plus the Netherlands and Hong Kong, as well as the Office of Drug Control.

Cann is in the grey, last trading at 66 cents at 10:12 am AEDT.

CAN by the numbers
More From The Market Herald
Alcidion Group (ASX:ALC) - Group Managing Director, Kate Quirke

" Alcidion (ASX:ALC) to raise $55m & acquire Silverlink

Alcidion (ALC) has announced plans to raise $55 million and buy patient software specialists, Silverlink PCS Software.
Actinogen Medical (ASX:ACW) - CEO & Managing Director, Dr Steven Gourlay

" Actinogen Medical (ASX:ACW) partners with Oxford University

Actinogen (ACW) has announced a collaboration with Oxford University researchers to investigate Xanamem and a condition called mild autonomous cortisol secretion (MACS).
Neuren Pharmaceuticals (ASX:NEU) - CEO, Jon Pilcher

" Neuren Pharmaceuticals (ASX:NEU) soars on ‘positive’ Rett syndrome trial results

Neuren Pharmaceuticals’ (NEU) shares have soared following positive top-line results from a phase three study on Rett syndrome.

" Recce Pharmaceuticals (ASX:RCE) spikes amid trial update

Shares in Recce Pharmaceuticals (RCE) have spiked amid a positive update in the clinical trial for the treatment of burn wound infections.